Related references
Note: Only part of the references are listed.Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation
Julie M. Vose et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma
Hirold Goto et al.
CANCER LETTERS (2013)
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
Franck Morschhauser et al.
EUROPEAN JOURNAL OF CANCER (2013)
Lenalidomide in lymphomas and chronic lymphocytic leukemia
Peter H. Wiernik
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
Shrub Bhatt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
Andre Goy et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas
Hiba El Hajj et al.
PLOS ONE (2013)
Extracavitary KSHV-associated Large B-Cell Lymphoma A Distinct Entity or a Subtype of Primary Effusion Lymphoma? Study of 9 Cases and Review of an Additional 43 Cases
Zeng-Gang Pan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
The Effects of Heat Shock Protein 90 Inhibitors on Apoptosis and Viral Replication in Primary Effusion Lymphoma Cells
Chizuka Higashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-?B pathway
Hiroki Goto et al.
CANCER SCIENCE (2012)
Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
Azhar R. Hussain et al.
PLOS ONE (2012)
Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?
Christoph A. Fux et al.
AIDS (2011)
Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells
Chiaki Saji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
Arun George Paul et al.
PLOS ONE (2011)
The emerging role of lenalidomide in the management of lymphoid malignancies
Sameer A. Batoo et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2011)
Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes
Carla Heise et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Convergence of Kaposi's Sarcoma-Associated Herpesvirus Reactivation with Epstein-Barr Virus Latency and Cellular Growth Mediated by the Notch Signaling Pathway in Coinfected Cells
Sophia Spadavecchia et al.
JOURNAL OF VIROLOGY (2010)
A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL
J. R. Brown et al.
LEUKEMIA (2010)
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Kristopher A. Sarosiek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of KSHV infected primary effusion lymphomas in NOD/SCID mice by γ-secretase inhibitor
Ke Lan et al.
CANCER BIOLOGY & THERAPY (2009)
Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-κB pathway
Naoko Takahashi-Makise et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma
P. Gasperini et al.
LEUKEMIA (2009)
Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells
Azhar R. Hussain et al.
LEUKEMIA & LYMPHOMA (2009)
Methotrexate-Associated Alterations of the Folate and Methyl-Transfer Pathway in the CSF of ALL Patients With and Without Symptoms of Neurotoxicity
Sandra Vezmar et al.
PEDIATRIC BLOOD & CANCER (2009)
Treatment of primary effusion lymphoma with highly active antiviral therapy in the setting of HIV infection
Diego Ripamonti et al.
AIDS (2008)
Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma
Adam Bryant et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma
Emmanuelle Boulanger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Treatment of plasma cell dyscrasias with lenalidomide
M. A. Dimopoulos et al.
LEUKEMIA (2008)
Primary effusion lymphoma - A series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis
Fadi Brimo et al.
CANCER CYTOPATHOLOGY (2007)
PS-341 or a combination of arsenic trioxide and interferon-α inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells
R. Abou-Merhi et al.
LEUKEMIA (2007)
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Sang-Hoon Sin et al.
BLOOD (2007)
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2006)
Successful eradication of relapsed primary effusion lymphoma with high-dose chemotherapy and autologous stem cell transplantation in a patient seronegative for human immunodeficiency virus
Jong-Ho Won et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
The pleiotropic effects of Kaposi's sarcoma herpesvirus
TF Schulz
JOURNAL OF PATHOLOGY (2006)
Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus
Masahiro Fujimuro et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
E Boulanger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-α
W Wu et al.
LEUKEMIA RESEARCH (2005)
Inhibition of phosphatidylinositol 3′-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells
S Uddin et al.
CLINICAL CANCER RESEARCH (2005)
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir
M Luppi et al.
LEUKEMIA (2005)
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells
H Matta et al.
CANCER BIOLOGY & THERAPY (2005)
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association
W Fan et al.
JOURNAL OF VIROLOGY (2005)
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: Case report and literature review
TW Waddington et al.
AIDS PATIENT CARE AND STDS (2004)
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas
J An et al.
LEUKEMIA (2004)
Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma
E Boulanger et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB
SK Ghosh et al.
BLOOD (2003)
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Y Aoki et al.
BLOOD (2003)
High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy
A Re et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study
C Simonelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma
J Kapelushnik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
A Carbone et al.
BLOOD (2001)
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy
L Hocqueloux et al.
AIDS (2001)
Share Paper
